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Background: Surgical repair is an effective method to treat ventricular septal defect (VSD) complicating
acute myocardial infarction (AMI). However, the mortality rate remains high. This study was designed to
assess the immediate and mid-term results of transcatheter closure of postinfarct muscular VSDs.
Methods: Data were retrospectively collected from 42 AMI patients who underwent attempted transcat-
heter VSD closure between 2008 and 2012 in seven heart centers of China.
Results: Nine patients underwent emergent VSD closure in the acute phase (within two weeks from
VSD) while the others underwent elective closure. The time between VSD occurrence and closure in
emergency group and elective group was 7.7±2.3 days and 35±14.5 days, respectively (p<0.01). The
percentage of procedure success in the emergency group and elective group was 77.8% (7/9) and 97%
(32/33), respectively (p=0.048). The hospital mortality was higher for emergent closure in comparison
to elective closure (66.7% vs. 6.1%, p<0.01). During a median follow-up of 25 months (0–58 months), two
patients died at 8 and 29 months, respectively, and no serious complications occurred in other patients.
Conclusion: Interventional postinfarct VSD closure is a safe and effective approach that can be per-
formed with a high procedural success rate, with favorable outcomes if it can be undertaken >14 days
postinfarct.
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Ventricular septal defect (VSD) complicating acute myocardial
nfarction (AMI) is a rare but fatal complication, occurring in
–3% of patients in the pre-reperfusion era [1,2]. VSD after AMI
as associated with extremely poor outcome, with in-hospital
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mortality rates in two studies of about 42.9% (n=2876) [3] and
47% (n=41021) [4] for surgically treated patients and 90% for
those treated medically [5,6]. With the development of reperfu-
sion therapies such as thrombolysis and percutaneous coronary
intervention (PCI), there was a signiﬁcant decrease in incidence
(0.2–0.5%) and mortality of postinfarction VSD [4,7]. Although
this decrease is encouraging, both early and long-term prognoses
after AMI-related VSD remain unsatisfactory. Surgical repair is a
traditional and effective method and favorable for survival [3,8].
However, the mortality rate remains high [3,9], and the incidence
of a large residual shunt and re-rupture after surgery reaches up
to 10–20% [10,11]. Among the patients who survived the periop-
erative period the ﬁve-year survival rates reported in two studies
were only 57.1% (n=1235) and 38% (n=189) [3,12]. With advances
in cardiac interventional techniques and devices, transcatheter
closure of VSD had become an alternative or a bridge to surgical
served.
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epair for patients with postinfarction VSD, mainly as anecdotal
ingle case reports [13] or as small series [14–17].We evaluated the
mmediate- and mid-term safety and efﬁcacy of transcatheter VSD
losure in 42 cases of AMIpatientswith the additional complication
f postinfarction VSD from seven Chinese heart centers.
aterials and methods
We conducted a retrospective chart review of all patients who
nderwent transcatheter closure of postinfarction VSD at seven
hinese heart centers from 2008 to 2012. Patients with congen-
tal muscular VSD or who could not undergo closure because
f too big size and other reasons were excluded. Primary data
ere abstracted from the electronic medical record or archived
ecords. Demographic information was collected from the time of
rocedure. Transthoracic echocardiography (TTE) measurements
ere collected before procedure and at latest follow-up focus-
ng on location of occluder, residual shunt, and cardiac function.
nvasive hemodynamic measurements and procedural informa-
ion were collected from catheterization records. All patients who
urvived the procedures were called to hospital for follow-up by
TE, echocardiography (ECG), and clinical examination between
arch and May 2013. The degree of residual shunt was assessed
y measuring the width of the color jet as it exited through the
entricular septum by TTE. It was classiﬁed as trivial for a width
1mm,mild for awidth between 1 and 2mm,moderate for awidth
etween 2 and 4mm, and severe for a width >4mm. Clinical data
ere collected concerning patient symptoms prior to procedure
nd at themost recent follow-up. Furthermore, patientswere iden-
iﬁed by change in symptoms (improved/worse/no change) based
pon their explicit descriptionof signiﬁcant change in symptomsas
ocumented in the medical record. Before intervention, informed
ritten consentwas obtained fromall patients or their parents. The
tudy was approved by the Ethics Committee of Changhai Hospital,
nd was carried out in accordance with the Declaration of Helsinki
1996) and all relevant Chinese laws. Two types of occluders were
sed in the study: the Amplatzer occluder (AGA Medical, Golden
alley, MN, USA) and the domestic SHSMA occluders (Shape Mem-
ry Alloy Ltd, Shanghai, China). The SHSMA occluder used was a
odiﬁed double-disk occluder, which was designed based on the
mplatzer occluder. Theonly differencebetween these twoocclud-
rs is the size of the left disk and the maximum diameter of the
aist. The diameter of the left disk is 14mm larger than that of
he waist in SHSMA occluder, while 10mm larger in Amplatzer
ccluders. The maximum diameter of the waist is 32mm in SHSMA
Fig. 1. Lateral views of the Amplatzer (A) and SHSMAlogy 64 (2014) 285–289
occluder, while 24mm in Amplatzer occluders. The waist length of
both SHSMA and Amplatzer occluders is 10mm (Fig. 1).
Statistical analysis
All continuous variables are expressed asmean± standard devi-
ation (SD) or median with range as appropriate, and discrete
variables are presented as frequencies and/or percentages. Com-
parisons of baseline data were performed using the chi-square test
or Fisher’s exact test (categorical variables) and Student’s t-test
or Wilcoxon rank-sum test as appropriate (continuous variables).
All tests were two-sided, and p-values <0.05 were considered as
indicating statistical signiﬁcance.
Results
Demographic data and clinical characteristics
A total of 42 patients qualiﬁed for inclusion. The mean age of
patients was 65±4.1 years and 43% (18/42) were female. The AMI
preceding the VSD was anterior in 19 and inferior/posterior in
23 patients. At the time of presentation, cardiogenic shock was
present in 16 patients (38.1%), and 18 patients (42.9%) had a history
of angina. Standard comorbidities were hypertension in 29 (69%),
hypercholesterolemia in 21 (50%), diabetes mellitus in 11 (26.2%),
active smoking in 17 (40.1%), and history of revascularization
in two (4.8%). The time from infarction to VSD occurrence was
2.5±1.4 days and the time from VSD occurrence to percutaneous
device closure was 29±17.2 days. Demographic and clinical
ﬁndings of patients are summarized in Table 1. In these patients,
nine (21.4%) underwent emergent closure (within two weeks) of a
post-MI VSD. All patients presenting with hypotension and heart
failure were supported by intra-aortic balloon pump (IABP).
Interventional VSD closure procedure and periprocedural
complications
Coronary angiography was performed prior to VSD closure in
all patients with 47.6%, 33.3%, and 19.1% having single-, double-,
and triple-vessel diseases. Successful device deployment was per-
formed in 39 of the 42 patients and 34 of them survived until
discharge. TheVSDswere located apically in 26patients andbasally
in 16 patients. Thirty-nine patients underwent successful transcat-
heter VSD closure including four patients with two defects and one
patient with three defects each which were closed by using two
separate devices except one patient with two defects was closed
(B) muscular ventricular septal defect occluders.
X.-D. Xu et al. / Journal of Cardio
Table 1
Demographic data and clinical characteristic of the two groups (median with range,
frequencies, and percentages).
Emergency Elective p value
Patients (n) 9 33 –
Gender (female), n% 5(55.6) 13 (39.4) 0.385
Age (years) 64 (58–72) 65 (55–74) 0.871
Comorbidities
Hypertension 6 (66.7%) 23 (69.7%) 0.862
Hypercholesterolemia 5 (55.6%) 16 (48.5%) 0.707
Diabetes mellitus 2 (22.2%) 9 (27.3%) 0.760
Medical history
Smoking 3 (33.3%) 14 (42.4%) 0.622
Stroke 1 (11.1%) 3 (9.1%) 0.855
Revascularization 0 (0%) 2 (6.1%) 0.449
Region of MI
Anterior 5 (55.6%) 14 (42.4%) 0.483
Inferior/posterior 4 (44.4%) 19 (57.6%) 0.483
Unstable angina 4 (44.4%) 14 (42.4%) 0.914
Cardiogenic shock 5 (55.6%) 11 (33.3%) 0.224
Occurrence VSD after MI, days 2 (1–5) 2 (1–7) 0.303
Occurrence VSD-closure, days 7 (5–12) 30 (18–86) <0.001
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erally produces progressive circulatory failure and death within a
short time. Compared to patients with AMI without VSD, patientsI, myocardial infarction; VSD, ventricular septal defect.
y using one occluder on the account of occurrence of acute left
entricular failure and another occluder could not be implanted.
he patient with three defects had a failed VSD closure in one of
is triple ventricular defects. The device success rate was 89.6%
43/48) and procedure success was 92.9% (39/42). The mean diam-
ter of the occluders is 18.0±3.1mm. A residual shunt was noted
t the time of procedure in 32 patients. Twenty-six patients had
ild residual shunts and eight of these disappeared at the time of
ischarge, while four had moderate residual shunts and two had
failed closure in one of their multi-defects had severe residual
hunts. Hemolysiswas found in one of these patients 10h after pro-
edure. Outcomes of transcatheter VSD closure are summarized in
able 2.
Altogether, three patients (7.1%) died during the study due to
rocedure-related complications. Two (acute phase) of these three
atients had a left ventricular rupture related to the manipulation
f the VSD positioning, resulting in a sudden cardiac death. In the
hird patient (elective phase), ventricular ﬁbrillation occurred after
able 2
atheterization data of the two groups (median with range, frequencies, and
ercentages).
Emergency Elective p value
Invasive hemodynamic data
Mean systolic BP 108 (94–122) 124 (106–155) 0.001
Qp/Qs 3.1 (2.3–3.6) 2.8 (2.2–3.4) 0.015
Coronary angiography
One-vessel disease 5 (55.6%) 15 (45.5%) 0.591
Two-vessel disease 3 (33.3%) 11 (33.3%) 1
Three-vessel disease 1 (11.1%) 7 (21.2%) 0.494
Number of defects
One 8 (88.9%) 29 (87.9%) 0.934
Two 1(11.1%) 3 (9.1%) 0.855
≥Three 0 (0%) 1 (3.0%) 0.597
VSD location
Apical 6 (66.7%) 20 (60.6%) 0.740
Basal 3 (33.3%) 13 (39.4%) 0.740
Occluder size (mm) 20 (14–30) 17 (14–24) 0.030
Procedure success 7 (77.8%) 32 (97.0%) 0.048
p/Qs, pulmonary to systemic ﬂow ratio; BP, blood pressure; VSD, ventricular septal
efect.logy 64 (2014) 285–289 287
crossing the VSD with the delivery sheath. The patient died despite
electrical conversion and chest compression.
Details of the ﬁve patients, four closed in acute phase and one
closed in elective phase, who died in the intensive care unit after
transcatheter therapy are as follows: the status of patient one was
good after successful transcatheter VSD closure; however, one day
later, the patient died of another new-onset septal perforation and
cardiogenic shock. Patient 2 was an old female (72 years) who died
of refractory heart failure and multiorgan failure. The third patient
who had two defects died of refractory heart failure and failed to
undergo the transcatheter VSD closure for the second ventricu-
lar defect. The fourth patient who had a 20-mm defect measured
from the left ventriculogramwas implanted a 30-mmASDoccluder
successfully. Unfortunately, hemolysis occurred 10h after the pro-
cedure and this patient died of renal failure. The status of patient
ﬁve was good after successful transcatheter VSD closure; how-
ever, aweek later, the patient died of anothermyocardial infarction
despite the application of dual antiplatelet therapy.
Follow-up data
We attempted to contact all the patients who survived the
procedures for follow-up. Thirty patients were contacted and the
remaining four were lost to follow-up. Twenty-ﬁve patients went
to their respective hospital for follow-up by TTE, ECG, and clinical
examination between March and May 2013. The median follow-
up time was 25 months (0–58 months). At the latest follow-up,
there were two cardiac deaths, which occurred at 8 and 29 months
after discharge, respectively. The TTE showed that the VSD devices
were placed in their appropriate position and VSD to be completely
closed in seven patients. Their functional capacity had improved to
New York Heart Association class I or II for 22 and class III for six
patients according to their explicit description. The follow-up data
are summarized in Table 3.
Discussion
VSD is one of the most serious complications of AMI that gen-with VSD were older, more likely to be women, had increased rate
of chronic renal disease, congestive heart failure, and cardiogenic
Table 3
Data of post-procedure and follow-up of the two groups (median with range,
frequencies, and percentages).
Emergency Elective p value
Residual shunt: immediate result
Mild 3 (33.3%) 23 (69.7%) 0.046
Moderate 2 (22.2%) 2 (6.1%) 0.143
Severe 1(11.1%) 1 (3.0%) 0.313
Residual shunt: before discharge
Mild 2 (22.2%) 18 (54.5%) 0.085
Moderate 0 (0%) 1 (3.0%) 0.597
Severe 0 (0%) 1 (3.0%) 0.597
Residual shunt: latest follow-up
Mild 2 (22.2%) 11 (33.3%) 0.523
Moderate 0 (0%) 1 (3.0%) 0.597
Severe 0 (0%) 1 (3.0%) 0.597
Complications
Death
On table 2 (22.2%) 1 (3.0%) 0.048
During hospitalization 4 (44.4%) 1 (3.0%) 0.001
After discharge 0 (0%) 2 (6.1%) 0.449
Hemolysis 1 (11.1%) 0 (0%) 0.053
Follow-up time, months 36 (27–44) 24 (0–58) 0.349
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hock, the absence of a history of angina or myocardial infarction
MI), and severe coronary stenosis or total occlusion without
ompensatory collateral circulation and were less likely to be
ypertensive or diabetic [4,9,18,19]. Optimized medical treatment
ncluding inotropic support, vasopressor drugs, and diuretic ther-
py for these patients is essential. However, attempts to stabilize
he patient’s condition with medical therapy often fail because
ost patients have a rapid deterioration and subsequently die. Cur-
ent guidelines of the American College of Cardiology–American
eart Association for the treatment of postinfarction VSD rec-
mmend immediate surgical repair, regardless of clinical status
class I recommendation) [20]. However, mortality rates in surgical
losure remain high at about 20–77% in current series to date.
he interventional approach is a less invasive option and might
llow for immediate complete VSD closure and stabilize the
emodynamics enough to function as an alternative or a bridge to
urgical repair, especially in patients with multi-organ failure [16].
This retrospective study described the experience of 42 patients
romsevenChinese heart centerswhounderwent attempted trans-
atheter VSD closure for the purpose of treating postinfarction
SD.We reported our experiencewith the percutaneous treatment
f postinfarction VSD using the Amplatzer or domestic SHSMA
ccluder device. The median length of time from infarction to VSD
ccurrence was two days [interquartile range (IQR) 1–3] and time
rom VSD to closure was 28 days (IQR: 21–36). The in-hospital
ortality rate (8/42) is concordant with data already published
rom other groups (6/29) [17]. But the mortality of urgent trans-
atheter VSD closure in our study was signiﬁcantly higher than the
reviously reported mortality [21]. The majority of the patients
6/9) who underwent urgent percutaneous VSD closure died in
he catheterization laboratory or during hospitalization. However,
mong the 33 patients who underwent elective VSD closure about
hree weeks after VSD, only two died and the status of the other
1 patients was good at the latest follow-up. Such a high survival
ate was perhaps attributed to the long time from VSD occurrence
ig. 2. Transcatheter postinfarction VSD closure in two patients without (A–C) and wit
SD (arrow). (B) Occluder was deployed, and mild residual shunt was found by angiograp
E) Arteriovenous wire loop was established and the rigid delivery sheath was advanced.
eft ventricular; VSD, ventricular septal defect.logy 64 (2014) 285–289
to percutaneous device closure (median 30 days, IQR: 26–39 days).
From our experience, it is responsible for improving outcomes to
close the VSDs after a 2–3 weeks delay to allow the surround-
ing tissue to develop a ﬁrm scar which can be ﬁrmly anchored
with occluders. It is not safe to deliver a sheath and close the
defect shortly after AMI because the surrounding myocardium is
too fragile. Therefore, the options for treatment depend on the
hemodynamic status of the patient. When the patient is hemo-
dynamically stable or has become stable after medication or
mechanical support with IABP, transcatheter closure or surgical
repair should be delayed until themargins of infarctedmuscle have
developed a relatively ﬁrm scar. When the patient is hemodynam-
ically unstable, transcatheter closure is not a principal choice and
perhaps an urgent surgical repair is favorable for survival.
The difﬁculty of transcatheter closure of ventricular septal
rupture is how to push the catheter through the septum defect.
According to our experience on transcatheter closure of congenital
muscular VSD, we ﬁrstly push right coronary angiography catheter
through the right femoral artery retrograde into the left ventricle.
Then we let the catheter tip point to left ventricular surface of
septum at left anterior oblique 45–60◦and cranial 25◦ and the
super-smooth guidewire is used to pass through the defect and the
arteriovenous wire loop is established. If the defect is located in the
front upper of the septal, it is difﬁcult to pass through the defect
to the arterial side. Then transvenous (femoral or jugular vein)
approach is a preferred choice and the guide wire can be inserted
directly into the descending aorta (Fig. 2). Except four patients,
all other patients underwent transcatheter closure through the
femoral vein due to operational convenience. In order to avoid
the ventricular rupture, we should let the catheter tip point to
left ventricular outﬂow tract but not apical to avoid damaging
the left ventricular free wall when we push the catheter through
the defect into the left ventricle. And we should pull back the
delivery catheter but not push the occluder to release the right
disc. In addition, the occluders are usually difﬁcult to ﬁx because of
h arteriovenous wire loop (D–F). (A) LV angiogram delineating the mid muscular
hy. (C) Occluder was released. (D) LV angiogram showed a muscular VSD (arrow).
(F) Occluder was deployed, and mild residual shunt was found by angiography. LV,
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he presence of the friable necrotic myocardial tissue around the
efect. For this reason, the design of SHSMA occluder was made
or better ﬁxation and the avoidance of disc displacement.
The study has some limitations. The ﬁrst limitation is the
elatively small patient population. Second, because of the retro-
pective study design, non-randomized study in hospitals in China,
he experience may not be universally representative. On the other
and, we are unable to certify that all potential confounders have
een examined. Third, follow-up in our study was relatively short
nd a few patients were not seen after discharge, and thus, these
atadonotprovide informationon thedurability of surgical closure
f post-MI VSD.
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